Press Releases

Press Releases

June 11, 2020
Establishment Labs’ Motiva Flora Tissue Expander Receives CE Mark
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has received CE Mark for the Motiva Flora Tissue Expander.
June 3, 2020
ESTA Announces Participation in the Goldman Sachs Global Healthcare Conference
NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer
May 26, 2020
ESTA Announces Participation in the Jefferies Virtual Healthcare Conference
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer
May 11, 2020
Establishment Labs Announces Participation in the UBS Virtual Global Healthcare Conference
NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer
May 7, 2020
Establishment Labs Reports Record First Quarter 2020 Financial Results
NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2020.
April 23, 2020
Establishment Labs to Announce First Quarter 2020 Financial Results on May 7
NEW YORK , April 23, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended March 31, 2020 after the
March 25, 2020
Establishment Labs Receives Issuance for Key U.S. Patent Covering Company’s Implant Surface Technology
NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the U.S. Patent & Trademark Office has issued a patent protecting
March 16, 2020
Establishment Labs Reports Fourth Quarter and Full Year 2019 Financial Results
NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended
March 3, 2020
Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16
NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the
February 25, 2020
ESTA Announces Participation at the Cowen and Company 40th Annual Health Care Conference
NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that CEO and Founder Juan José Chacón-Quirós will participate at the
Displaying 1 - 10 of 14